Industry group says FDA botched COVID-19 convalescent plasma guidance
pharmaphorum
AUGUST 27, 2020
The problem lies with the requirement that each unit of plasma includes information on the concentration of antibody titres, something which wasn’t required for CCP units collected ahead of the EUA on 23 August. As it stands, only one or two people out of 100 would be expected to die if they had COVID-19, so the claim makes little sense.
Let's personalize your content